Status:
COMPLETED
Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)
Lead Sponsor:
Regina Elena Cancer Institute
Conditions:
Primary Peritoneal Neoplasm
Secondary Peritoneal Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to assess whether in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) the use of a protocol of intravenous fluid therapy combined with goal dir...
Eligibility Criteria
Inclusion
- Patients selected for Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Exclusion
- Patients under the age of 18, patients with hemodynamically significant aortic regurgitation and heart rhythm disorders
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01882920
Start Date
June 1 2010
End Date
September 1 2012
Last Update
April 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regina Elena CI
Rome, Italy, 00144